LUNG - Pulmonx Corp - SEC Form 4 Insider Trading Screener

Manufactured Goods - Specialty Instruments - Surgical & Medical Instruments & Apparatus - LUNG (1127537)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
48 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-09-12
LUNGFrench Glendon E. IIIDirS - Sale$8.09-20,0001,111,974-2%-$161,800
2024-09-03
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$6.70-4,586295,433-2%-$30,721
2024-09-03
LUNGLehman David AaronGCS - Sale$6.69-5,765203,348-3%-$38,576
2024-08-20
LUNGWilliamson Steven S.Pres, CEOP - Purchase$6.84+14,245219,531+7%+$97,436
2024-06-24
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$6.16-1,184300,0190%-$7,293
2024-06-03
LUNGLehman David AaronGCS - Sale$6.97-5,475209,113-3%-$38,161
2024-06-03
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$6.97-4,297301,203-1%-$29,950
2024-05-22
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$8.71-1,184305,5000%-$10,313
2024-04-22
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$7.49-1,184306,6840%-$8,868
2024-03-22
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$9.36-1,184307,8680%-$11,082
D
2024-03-01
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale+OE$9.06-3,097274,452-1%-$28,059
D
2024-03-01
LUNGMcKune JohnInterim CFOS - Sale+OE$9.06-1,07861,810-2%-$9,767
D
2024-03-01
LUNGLehman David AaronGCS - Sale+OE$9.06-4,351179,988-2%-$39,420
2024-03-01
LUNGFrench Glendon E. IIIPres, CEOS - Sale$9.06-6,9541,116,758-1%-$63,003
2024-02-22
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$14.20-1,184243,0490%-$16,813
2024-02-15
LUNGFrench Glendon E. IIIPres, CEOS - Sale$14.60-20,0001,121,344-2%-$292,000
2024-01-22
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$13.13-1,184244,2330%-$15,546
2024-01-18
LUNGFrench Glendon E. IIIPres, CEOS - Sale$12.77-10,0001,141,344-1%-$127,700
2023-12-22
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$12.75-1,184245,4170%-$15,096
2023-12-21
LUNGFrench Glendon E. IIIPres, CEOS - Sale$12.42-10,0001,151,344-1%-$124,200
2023-12-01
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$10.34-2,868246,601-1%-$29,655
2023-12-01
LUNGMcKune JohnInterim CFOS - Sale$10.34-94247,647-2%-$9,739
2023-12-01
LUNGLehman David AaronGCS - Sale$10.34-3,809149,839-2%-$39,381
2023-12-01
LUNGFrench Glendon E. IIIPres, CEOS - Sale$10.34-6,6761,161,344-1%-$69,030
2023-11-22
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$10.60-1,184249,4690%-$12,550
2023-10-23
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$8.35-1,184250,6530%-$9,886
2023-09-22
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$10.51-1,184251,8370%-$12,444
2023-09-01
LUNGSung DerrickCFOS - Sale$10.00-4,219391,041-1%-$42,201
2023-09-01
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$10.01-2,843253,021-1%-$28,458
2023-09-01
LUNGLehman David AaronGCS - Sale$10.01-3,772153,648-2%-$37,758
2023-09-01
LUNGFrench Glendon E. IIIPres, CEOS - Sale$10.01-6,5271,168,020-1%-$65,335
2023-08-23
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$10.54-1,184255,8640%-$12,479
2023-07-20
LUNGFrench Glendon E. IIIPres, CEOS - Sale$12.68-15,0001,174,547-1%-$190,200
2023-06-15
LUNGFrench Glendon E. IIIPres, CEOS - Sale$12.68-10,0001,189,547-1%-$126,800
2023-06-01
LUNGSung DerrickCFOS - Sale$11.49-4,222395,260-1%-$48,507
2023-06-01
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$11.48-2,845257,048-1%-$32,661
2023-06-01
LUNGLehman David AaronGCS - Sale$11.48-3,776157,420-2%-$43,348
2023-06-01
LUNGFrench Glendon E. IIIPres, CEOS - Sale$11.48-6,5331,199,547-1%-$75,009
D
2023-03-01
LUNGSung DerrickCFOS - Sale+OE$11.03-1,264399,4820%-$13,942
D
2023-03-01
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale+OE$11.03-1,206259,8930%-$13,302
D
2023-03-01
LUNGLehman David AaronGCS - Sale+OE$11.03-1,264161,196-1%-$13,942
D
2023-03-01
LUNGFrench Glendon E. IIIPres, CEOS - Sale+OE$11.03-2,8951,206,0800%-$31,932
2022-12-01
LUNGFrench Glendon E. IIIPres, CEOS - Sale$5.93-3,6311,034,3130%-$21,532
2022-12-01
LUNGLehman David AaronGCS - Sale$5.93-1,06944,160-2%-$6,339
2022-12-01
LUNGRose Geoffrey BeranChief Commercial OfficerS - Sale$5.93-1,055181,037-1%-$6,256
2022-12-01
LUNGSung DerrickCFOS - Sale$5.93-1,069262,7460%-$6,339
2022-11-29
LUNGLynch Alissa HsuDirP - Purchase$5.51+1,70011,910+17%+$9,367
2022-11-08
LUNGFerrari RichardDirP - Purchase$5.31+5,43830,035+22%+$28,874

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top